- Home
- TCBX vs SLDB Comparison
TCBX vs SLDB Comparison
Compare TCBX & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBX
- SLDB
- Stock Information
- Founded
- TCBX 2008
- SLDB 2013
- Country
- TCBX United States
- SLDB United States
- Employees
- TCBX N/A
- SLDB N/A
- Industry
- TCBX Banks
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TCBX Finance
- SLDB Health Care
- Exchange
- TCBX Nasdaq
- SLDB Nasdaq
- Market Cap
- TCBX 481.8M
- SLDB 464.1M
- IPO Year
- TCBX 2021
- SLDB 2018
- Fundamental
- Price
- TCBX $36.66
- SLDB $4.22
- Analyst Decision
- TCBX Hold
- SLDB Strong Buy
- Analyst Count
- TCBX 4
- SLDB 10
- Target Price
- TCBX $41.67
- SLDB $14.70
- AVG Volume (30 Days)
- TCBX 68.5K
- SLDB 991.5K
- Earning Date
- TCBX 10-22-2025
- SLDB 11-03-2025
- Dividend Yield
- TCBX N/A
- SLDB N/A
- EPS Growth
- TCBX 38.90
- SLDB N/A
- EPS
- TCBX 3.56
- SLDB N/A
- Revenue
- TCBX $192,224,000.00
- SLDB N/A
- Revenue This Year
- TCBX $24.66
- SLDB N/A
- Revenue Next Year
- TCBX $17.56
- SLDB N/A
- P/E Ratio
- TCBX $10.53
- SLDB N/A
- Revenue Growth
- TCBX 20.96
- SLDB N/A
- 52 Week Low
- TCBX $25.17
- SLDB $2.41
- 52 Week High
- TCBX $41.25
- SLDB $7.37
- Technical
- Relative Strength Index (RSI)
- TCBX 43.62
- SLDB 30.67
- Support Level
- TCBX $35.77
- SLDB $3.91
- Resistance Level
- TCBX $40.58
- SLDB $6.09
- Average True Range (ATR)
- TCBX 1.44
- SLDB 0.39
- MACD
- TCBX -0.11
- SLDB -0.21
- Stochastic Oscillator
- TCBX 20.76
- SLDB 9.19
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.